Page 24 - Use Authorization News Today

This beaten-down vaccine stock appears to be dirt cheap right now.

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

"The data right now really support vaccine and boosters in particular to maintain immunity."

The Centers for Disease Control and Prevention contracted with laboratories to sequence the SARS-CoV-2 genome from positive samples across the United States to enable public health officials to investigate the impact of variants on disease severity as well as the effectiveness of vaccines and treatment. Herein we present the initial results correlating RT-PCR quality control metrics with sample collection and sequencing methods from full SARS-CoV-2 viral genomic sequencing of 24,441 positive pat...

FDA okays Janssen as booster shot

/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac...

U.S. pharmaceutical company Pfizer and its German COVID-19 vaccine partner, BioNTech, announced Thursday recent trials show booster doses of its vaccine effectively protect healthy children ages 5 to 11 from the omicron variant of the coronavirus. In a press release, the companies say their phase-three trials examined data from 140 children ages 5 through 11…

/PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has extended by three months...

MONMOUTH JUNCTION, N.J., April 14, 2022 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening con...

The companies plan to apply for US Emergency Use Authorization of a booster dose in the age group in coming days